These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8846837)
1. Immunocytochemical location and hormonal control of androgen receptors in lacrimal tissues of the female MRL/Mp-lpr/lpr mouse model of Sjögren's syndrome. Ono M; Rocha FJ; Sullivan DA Exp Eye Res; 1995 Dec; 61(6):659-66. PubMed ID: 8846837 [TBL] [Abstract][Full Text] [Related]
2. Androgen stimulation of lacrimal gland function in mouse models of Sjögren's syndrome. Sullivan DA; Edwards JA J Steroid Biochem Mol Biol; 1997 Feb; 60(3-4):237-45. PubMed ID: 9191982 [TBL] [Abstract][Full Text] [Related]
3. Impact of androgen therapy in Sjögren's syndrome: hormonal influence on lymphocyte populations and Ia expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Sato EH; Ariga H; Sullivan DA Invest Ophthalmol Vis Sci; 1992 Jul; 33(8):2537-45. PubMed ID: 1634351 [TBL] [Abstract][Full Text] [Related]
4. Androgen control of autoimmune expression in lacrimal glands of MRL/Mp-lpr/lpr mice. Ariga H; Edwards J; Sullivan DA Clin Immunol Immunopathol; 1989 Dec; 53(3):499-508. PubMed ID: 2805454 [TBL] [Abstract][Full Text] [Related]
5. Comparative influence of steroid hormones and immunosuppressive agents on autoimmune expression in lacrimal glands of a female mouse model of Sjögren's syndrome. Sato EH; Sullivan DA Invest Ophthalmol Vis Sci; 1994 Apr; 35(5):2632-42. PubMed ID: 8163351 [TBL] [Abstract][Full Text] [Related]
6. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice. Toda I; Wickham LA; Sullivan DA Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797 [TBL] [Abstract][Full Text] [Related]
7. Lacrimal gland innervation is not altered with the onset and progression of disease in a murine model of Sjögren's syndrome. Zoukhri D; Hodges RR; Dartt DA Clin Immunol Immunopathol; 1998 Nov; 89(2):126-33. PubMed ID: 9787114 [TBL] [Abstract][Full Text] [Related]
8. Testosterone Influence on Gene Expression in Lacrimal Glands of Mouse Models of Sjögren Syndrome. Morthen MK; Tellefsen S; Richards SM; Lieberman SM; Rahimi Darabad R; Kam WR; Sullivan DA Invest Ophthalmol Vis Sci; 2019 May; 60(6):2181-2197. PubMed ID: 31108549 [TBL] [Abstract][Full Text] [Related]
9. Ca2+ signaling by cholinergic and alpha1-adrenergic agonists is up-regulated in lacrimal and submandibular glands in a murine model of Sjögren's syndrome. Zoukhri D; Hodges RR; Rawe IM; Dartt DA Clin Immunol Immunopathol; 1998 Nov; 89(2):134-40. PubMed ID: 9787115 [TBL] [Abstract][Full Text] [Related]
10. ICAM-1 expression predisposes ocular tissues to immune-based inflammation in dry eye patients and Sjögrens syndrome-like MRL/lpr mice. Gao J; Morgan G; Tieu D; Schwalb TA; Luo JY; Wheeler LA; Stern ME Exp Eye Res; 2004 Apr; 78(4):823-35. PubMed ID: 15037117 [TBL] [Abstract][Full Text] [Related]
11. Gender- and androgen-related influence on the expression of proto-oncogene and apoptotic factor mRNAs in lacrimal glands of autoimmune and non-autoimmune mice. Toda I; Sullivan BD; Wickham LA; Sullivan DA J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):49-61. PubMed ID: 10619357 [TBL] [Abstract][Full Text] [Related]
12. Impact of gender on exocrine gland inflammation in mouse models of Sjögren's syndrome. Toda I; Sullivan BD; Rocha EM; Da Silveira LA; Wickham LA; Sullivan DA Exp Eye Res; 1999 Oct; 69(4):355-66. PubMed ID: 10504269 [TBL] [Abstract][Full Text] [Related]
13. Impaired neurotransmitter release from lacrimal and salivary gland nerves of a murine model of Sjögren's syndrome. Zoukhri D; Kublin CL Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):925-32. PubMed ID: 11274068 [TBL] [Abstract][Full Text] [Related]
14. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice. Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporine therapy suppresses ocular and lacrimal gland disease in MRL/Mp-lpr/lpr mice. Jabs DA; Lee B; Burek CL; Saboori AM; Prendergast RA Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):377-83. PubMed ID: 8603842 [TBL] [Abstract][Full Text] [Related]
16. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome. Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators in autoimmune lacrimal gland disease in MRL/Mpj mice. Jabs DA; Gérard HC; Wei Y; Campbell AL; Hudson AP; Akpek EK; Lee B; Prendergast RA; Whittum-Hudson JA Invest Ophthalmol Vis Sci; 2004 Jul; 45(7):2293-8. PubMed ID: 15223808 [TBL] [Abstract][Full Text] [Related]
18. Role of Matrix Metalloproteinases 2 and 9 in Lacrimal Gland Disease in Animal Models of Sjögren's Syndrome. Aluri HS; Kublin CL; Thotakura S; Armaos H; Samizadeh M; Hawley D; Thomas WM; Leavis P; Makarenkova HP; Zoukhri D Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5218-28. PubMed ID: 26244298 [TBL] [Abstract][Full Text] [Related]
19. Dry eye management in a Sjögren's syndrome mouse model by inhibition of p38-MAPK pathway. Ma X; Zou J; He L; Zhang Y Diagn Pathol; 2014 Jan; 9():5. PubMed ID: 24443980 [TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of androgen analogues in suppressing lacrimal gland inflammation in a mouse model (MRL/lpr) of Sjögren's syndrome. Rocha FJ; Sato EH; Sullivan BD; Sullivan DA Adv Exp Med Biol; 1994; 350():697-700. PubMed ID: 8030558 [No Abstract] [Full Text] [Related] [Next] [New Search]